Particle.news

Download on the App Store

Kenvue Beats Q1 Estimates, Raises 2025 Sales Outlook

The consumer health giant reports $3.74 billion in sales, upgrades guidance, and announces CFO transition amid tariff challenges.

Image
Image

Overview

  • Kenvue posted adjusted earnings per share of $0.24 and net sales of $3.74 billion for Q1 2025, surpassing analyst expectations.
  • The company raised its 2025 net sales growth forecast to 1%-3%, up from a prior range of -1% to 1%, while maintaining organic sales growth guidance at 2%-4%.
  • Tariff-related pressures are expected to weigh on operating income margins, with adjusted EPS projected to remain flat for the year.
  • Amit Banati will replace Paul Ruh as Kenvue’s Chief Financial Officer starting next Monday, bringing experience from his previous role at Kellanova.
  • Kenvue shares rose over 6% following the earnings report and are up approximately 8% year-to-date.